Fig. 1From: Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional studyAvailability of therapeutic drug monitoring of beta-lactams and ciprofloxacinBack to article page